Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease

被引:40
作者
Marchesi, Alessandra [1 ]
Rigante, Donato [2 ,3 ]
Cimaz, Rolando [4 ,5 ]
Ravelli, Angelo [6 ]
Tarissi de Jacobis, Isabella [1 ]
Rimini, Alessandro [7 ]
Cardinale, Fabio [8 ]
Cattalini, Marco [9 ]
De Zorzi, Andrea [1 ]
Dellepiane, Rosa Maria [10 ]
Salice, Patrizia [11 ]
Secinaro, Aurelio [1 ]
Taddio, Andrea [12 ,13 ]
Palma, Paolo [1 ]
El Hachem, Maya [1 ]
Cortis, Elisabetta [14 ]
Maggio, Maria Cristina [15 ]
Corsello, Giovanni [15 ]
Villani, Alberto [1 ]
机构
[1] Bambino Gesu Pediat Hosp, Rome, Italy
[2] Fdn Policlin A Gemelli, Dept Life Sci & Publ Hlth, IRCCS, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Rome, Italy
[4] ASST Gaetano Pini CTO, Pediat Rheumatol, Milan, Italy
[5] Univ Milan, Milan, Italy
[6] Univ Genoa, Pediat & Rheumatol Unit, Ist Giannina Gaslini, IRCCS, Genoa, Italy
[7] Ist Giannina Gaslini, IRCCS, Genoa, Italy
[8] AOU Policlin Giovanni XXIII, Dept Pediat, Bari, Italy
[9] Univ Brescia, Pediat Clin, ASST Spedali Civili Brescia, Brescia, Italy
[10] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UOC Pediat, UOS Pediat Immunol, Milan, Italy
[11] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Sect Pediat Cardiovasc Dis, Milan, Italy
[12] Univ Trieste, Trieste, Italy
[13] IRCCS Burlo Garofolo, Inst Child & Maternal Hlth, Trieste, Italy
[14] S Eugenio Hosp, UOC Pediat, Rome, Italy
[15] Univ Palermo, Palermo, Italy
关键词
Kawasaki disease; Coronary artery abnormalities; Intravenous immunoglobulin; Aspirin; Children; CORONARY-ARTERY ABNORMALITIES; INTRAVENOUS GAMMA-GLOBULIN; LONG-TERM MANAGEMENT; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; HEALTH-PROFESSIONALS; RISK-FACTORS; FOLLOW-UP; IMMUNOGLOBULIN; CHILDREN;
D O I
10.1186/s13052-021-00962-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim of these revised recommendations for the general management of Kawasaki disease is to encourage its prompter recognition and warrant the most appropriate therapy, based on ascertained scientific data, raising awareness of the complications related to misdiagnosis or delayed treatment. A set of 20 synthetic operative statements is herein provided, including the definition of Kawasaki disease, its protean presentations, clinical course and seminal treatment modalities of all disease phases. The application of these recommendations should improve prognosis of Kawasaki disease and prevent the progression to permanent vascular abnormalities, thereby diminishing morbidity and mortality.
引用
收藏
页数:12
相关论文
共 85 条
  • [1] Cardiac Catheterization in Assessment and Treatment of Kawasaki Disease in Children and Adolescents
    Agrawal, Hitesh
    Qureshi, Athar M.
    [J]. CHILDREN-BASEL, 2019, 6 (02):
  • [2] AKAGI T, 2011, INT J CARDIOL, V41, P53, DOI DOI 10.4070/KCJ.2011.41.2.53
  • [3] Platelets in Kawasaki disease: Is this only a numbers game or something beyond?
    Arora, Kanika
    Guleria, Sandesh
    Jindal, Ankur Kumar
    Rawat, Amit
    Singh, Surjit
    [J]. GENES & DISEASES, 2020, 7 (01) : 62 - 66
  • [4] Management of coronary artery aneurysms using abciximab in children with Kawasaki disease
    Bachlava, Evangelia
    Loukopoulou, Sophia
    Karanasios, Evangelos
    Chrousos, George
    Michos, Athanasios
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 65 - 69
  • [5] Burns J C, 2001, Adv Pediatr, V48, P157
  • [6] International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease
    Burns, Jane C.
    Kone-Paut, Isabelle
    Kuijpers, Taco
    Shimizu, Chisato
    Tremoulet, Adriana
    Arditi, Moshe
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) : 268 - 276
  • [7] Infliximab Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease
    Burns, Jane C.
    Best, Brookie M.
    Mejias, Asuncion
    Mahony, Lynn
    Fixler, David E.
    Jafri, Hasan S.
    Melish, Marian E.
    Jackson, Mary Anne
    Asmar, Basim I.
    Lang, David J.
    Connor, James D.
    Capparelli, Edmund V.
    Keen, Monica L.
    Mamun, Khalid
    Keenan, Gregory F.
    Ramilo, Octavio
    [J]. JOURNAL OF PEDIATRICS, 2008, 153 (06) : 833 - 838
  • [8] Intravenous gamma-globulin treatment and retreatment in Kawasaki disease
    Burns, JC
    Capparelli, EV
    Brown, JA
    Newburger, JW
    Glode, MP
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (12) : 1144 - 1148
  • [9] Characteristics of Kawasaki disease in infants younger than six months of age
    Chang, FY
    Hwang, B
    Chen, SJ
    Lee, PC
    Meng, CCL
    Lu, JH
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (03) : 241 - 244
  • [10] An update on Kawasaki disease
    Cimaz, R
    Falcini, F
    [J]. AUTOIMMUNITY REVIEWS, 2003, 2 (05) : 258 - 263